Rein Therapeutics Inc.
RNTX
$1.16
$0.043.57%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
The Cerbat Gem
5/1/2026
-
Seeking Alpha - Healthcare
5/1/2026
-
Globe Newswire
4/29/2026
-
Globe Newswire
4/26/2026
-
MarketBeat
4/2/2026
-
TipRanks Financial Blog
4/2/2026
-
The Fly
3/27/2026
-
Ticker Report
3/3/2026
-
TipRanks Financial Blog
3/3/2026
-
The Fly
3/3/2026
-
Globe Newswire
3/2/2026
-
TipRanks Financial Blog
1/22/2026
-
TipRanks Financial Blog
1/21/2026
-
Ticker Report
1/21/2026
-
The Fly
1/20/2026
-
GuruFocus
1/20/2026
-
The Fly
1/20/2026
-
The Fly
1/20/2026
-
The Fly
1/20/2026
-
GuruFocus
1/20/2026
-
Globe Newswire
1/16/2026
-
TipRanks Financial Blog
1/5/2026
-
Ticker Report
11/19/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
737 802 1989
Address
12407 N. Mopac Expy.
Austin, TX 78758
Austin, TX 78758
Country
Year Founded
Business Description
Sector
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The...
more